Vascular inflammation and abnormal aortic histomorphometry in patients after pulsatile- and continuous-flow left ventricular assist device placement

Journal of Heart and Lung Transplantation

Volumn 35, Issue 9, 2016, Pages 1085-1091

  Lee, Mike ^a   Akashi, Hirokazu ^a   Kato, Tomoko S ^a   Takayama, Hiroo ^b   Wu, Christina ^a   Xu, Katherine ^a   Collado, Elias ^a   Weber, Matthew P ^a   Kennel, Peter J ^a   Brunjes, Danielle L ^a   Ji, Ruiping ^a   Naka, Yoshifumi ^b   George, Isaac ^a   Mancini, Donna ^a   Farr, Maryjane ^a   Christian Schulze, P ^a,c  

^a Department of Medicine   (United States)

^b Division of Cardiothoracic Surgery   (United States)

^c FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

adhesion molecule; aorta; heart failure; histology; inflammation; left ventricular assist device

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AORTA DISEASE; AORTA MEDIA; AORTA ROOT; AORTA WALL; AORTIC TISSUE; ARTERY DIAMETER; ARTICLE; CLINICAL ARTICLE; CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE; ECHOCARDIOGRAPHY; FEMALE; HEART TRANSPLANTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEFT VENTRICULAR ASSIST DEVICE; MACROPHAGE; MALE; MIDDLE AGED; MORPHOMETRICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULSATILE FLOW LEFT VENTRICULAR ASSIST DEVICE; RETROSPECTIVE STUDY; T LYMPHOCYTE; TUNICA MEDIA; VASCULITIS; WESTERN BLOTTING; AORTA; HEART ASSIST DEVICE; HEART FAILURE; INFLAMMATION; TREATMENT OUTCOME;

AORTA; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; INFLAMMATION; TREATMENT OUTCOME;

EID: 84958582325     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2015.12.027     Document Type: Article

References (22)

1. 1 Rogers, J.G., Aaronson, K.D., Boyle, A.J., et al. Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. J Am Coll Cardiol 55 (2010), 1826–1834.
2. 2 Slaughter, M.S., Rogers, J.G., Milano, C.A., et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 361 (2009), 2241–2251.
3. 3 Slaughter, M.S., Pagani, F.D., Rogers, J.G., et al. Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant 29:suppl (2010), S1–39.
4. 4 Demirozu, Z.T., Radovancevic, R., Hochman, L.F., et al. Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device. J Heart Lung Transplant 30 (2011), 849–853.
5. 5 Uriel, N., Pak, S.W., Jorde, U.P., et al. Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation. J Am Coll Cardiol 56 (2010), 1207–1213.
6. 6 Kato, T.S., Ota, T., Schulze, P.C., et al. Asymmetric pattern of cerebrovascular lesions in patients after left ventricular assist device implantation. Stroke 43 (2012), 872–874.
7. 7 Trachtenberg, B.H., Cordero-Reyes, A.M., Aldeiri, M., et al. Persistent blood stream infection in patients supported with a continuous-flow left ventricular assist device is associated with an increased risk of cerebrovascular accidents. J Card Fail 21 (2015), 119–125.
8. 8 Cowger, J., Pagani, F.D., Haft, J.W., et al. The development of aortic insufficiency in left ventricular assist device-supported patients. Circ Heart Fail 3 (2010), 668–674.
9. 9 Pak, S.W., Uriel, N., Takayama, H., et al. Prevalence of de novo aortic insufficiency during long-term support with left ventricular assist devices. J Heart Lung Transplant 29 (2010), 1172–1176.
10. 10 Najjar, S.S., Slaughter, M.S., Pagani, F.D., et al. An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial. J Heart Lung Transplant 33 (2014), 23–34.
11. 11 Starling, R.C., Moazami, N., Silvestry, S.C., et al. Unexpected abrupt increase in left ventricular assist device thrombosis. N Engl J Med 370 (2014), 33–40.
12. 12 Chokshi, A., Drosatos, K., Cheema, F.H., et al. Ventricular assist device implantation corrects myocardial lipotoxicity, reverses insulin resistance, and normalizes cardiac metabolism in patients with advanced heart failure. Circulation 125 (2012), 2844–2853.
13. 13 Kato, T.S., Chokshi, A., Singh, P., et al. Markers of extracellular matrix turnover and the development of right ventricular failure after ventricular assist device implantation in patients with advanced heart failure. J Heart Lung Transplant 31 (2012), 37–45.
14. 14 Park, S.J., Milano, C.A., Tatooles, A.J., et al. Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy. Circ Heart Fail 5 (2012), 241–248.
15. 15 Templeton, D.L., John, R., Painter, P., et al. Effects of the left ventricular assist device on the compliance and distensibility of the carotid artery. Heart Vessels 28 (2013), 377–384.
16. 16 Rose, E.A., Gelijns, A.C., Moskowitz, A.J., et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 345 (2001), 1435–1443.
17. 17 Uriel, N., Morrison, K.A., Garan, A.R., et al. Development of a novel echocardiography ramp test for speed optimization and diagnosis of device thrombosis in continuous-flow left ventricular assist devices: the Columbia ramp study. J Am Coll Cardiol 60 (2012), 1764–1775.
18. 18 Segura, A.M., Gregoric, I., Radovancevic, R., et al. Morphologic changes in the aortic wall media after support with a continuous-flow left ventricular assist device. J Heart Lung Transplant 32 (2013), 1096–1100.
19. 19 Slaughter, M.S., Ising, M.S., Tamez, D., et al. Increase in circadian variation after continuous-flow ventricular assist device implantation. J Heart Lung Transplant 29 (2010), 695–697.
20. 20 Bartoli, C.R., Giridharan, G.A., Litwak, K.N., et al. Hemodynamic responses to continuous versus pulsatile mechanical unloading of the failing left ventricle. ASAIO J 56 (2010), 410–416.
21. 21 Westaby, S., Bertoni, G.B., Clelland, C., et al. Circulatory support with attenuated pulse pressure alters human aortic wall morphology. J Thorac Cardiovasc Surg 133 (2007), 575–576.
22. 22 Galkina, E., Ley, K., Vascular adhesion molecules in atherosclerosis. Arterioscler Thromb Vasc Biol 27 (2007), 2292–2301.